HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Porokeratosis of Mibelli following bone marrow transplantation.

AbstractBACKGROUND:
Porokeratosis is a rare disorder of keratinization with both autosomal dominant and acquired forms. Immunosuppression has been associated with the development of porokeratosis in numerous case reports and series. To our knowledge, however, only five cases of porokeratosis have been reported following bone marrow transplantation.
RESULTS:
We report five cases of porokeratosis of Mibelli following bone marrow transplantation. The diagnosis of porokeratosis was made between 1 and 13 years post-transplantation. The underlying malignancy in four of the five cases was leukemia, while the fifth patient had non-Hodgkin's lymphoma. Porokeratosis developed during remission in the four leukemia patients, whereas, in the fifth patient, it occurred during a relapse of lymphoma.
CONCLUSIONS:
Porokeratosis may develop following bone marrow transplantation. Our five cases double the number reported in the medical literature, and the incidence of porokeratosis following bone marrow transplantation may be significantly higher than previously recognized. As cutaneous carcinomas have been reported in association with porokeratosis, careful surveillance for porokeratosis in bone marrow transplant recipients is warranted.
AuthorsAndrew F Alexis, Klaus Busam, Patricia L Myskowski
JournalInternational journal of dermatology (Int J Dermatol) Vol. 45 Issue 4 Pg. 361-5 (Apr 2006) ISSN: 0011-9059 [Print] England
PMID16650158 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Bone Marrow Transplantation (adverse effects)
  • Female
  • Humans
  • Immunosuppression Therapy (adverse effects)
  • Leukemia (therapy)
  • Lymphoma, Non-Hodgkin (therapy)
  • Male
  • Middle Aged
  • Porokeratosis (etiology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: